Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00910650
What this trial is testing

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 14
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Not applicableLooking for participantsNCT07112170
What this trial is testing

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaOligoProgressive Metastatic Disease
University Health Network, Toronto 52
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Large-scale testing (Phase 3)Looking for participantsNCT05502900
What this trial is testing

Adjuvant Melatonin for Uveal Melanoma

Who this might be right for
Uveal MelanomaUveal Melanoma, Posterior, Medium/Large SizeEye Cancer, Intraocular Melanoma
Gustav Stalhammar 100
Testing effectiveness (Phase 2)Study completedNCT01266967
What this trial is testing

GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

Who this might be right for
Melanoma and Brain Metastases
GlaxoSmithKline 172
Testing effectiveness (Phase 2)Study completedNCT00984464
What this trial is testing

Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Oncolytics Biotech 14
Not applicableStudy completedNCT02663232
What this trial is testing

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

Who this might be right for
Metastatic Cancers
Hoffmann-La Roche 264
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680
What this trial is testing

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more
M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT02027961
What this trial is testing

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Who this might be right for
Melanoma
MedImmune LLC 68
Not applicableEnded earlyNCT03709771
What this trial is testing

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

Who this might be right for
Renal Cell CarcinomaHypertensionMelanoma+1 more
Vanderbilt University Medical Center 2
Not applicableActive Not RecruitingNCT07531121
What this trial is testing

CtDNA for Risk Stratification in Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Herlev and Gentofte Hospital 296
Testing effectiveness (Phase 2)Study completedNCT00019214
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01264081
What this trial is testing

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Who this might be right for
Malignant Melanoma
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03175432
What this trial is testing

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Who this might be right for
BRAF V600 Wild TypeClinical Stage IV Cutaneous Melanoma AJCC v8Intracranial Melanoma+4 more
M.D. Anderson Cancer Center 29
Not applicableStudy completedNCT04789421
What this trial is testing

Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management

Who this might be right for
Cutaneous Melanoma
Azienda Ospedaliero-Universitaria di Modena 3,248
Testing effectiveness (Phase 2)Active Not RecruitingNCT03693014
What this trial is testing

Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Who this might be right for
Metastatic CancerMelanoma CancerLung Cancer+3 more
Memorial Sloan Kettering Cancer Center 69
Not applicableStudy completedNCT01775514
What this trial is testing

A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics

Who this might be right for
Cancer
Hoffmann-La Roche 32,277
Next Page